Please login to the form below

Opinion piece: Patient-centricity and pharma – where are we now?

Patient-centricity is a term that has gained currency in the pharma industry in recent years, and most major companies in the sector are now dedicating resources to ensure that they put the wishes and needs of patients centre-stage in all of their business activities.
But questions still remain before it is likely to be completely adopted by the pharma industry, such as how should the industry define what true patient-centricity is, and how should progress be measured?  

Following active monitoring of developments in patient-centricity this year, gauging sentiment in the industry about progress so far, and what work still needs to be done, in a recent webinar, Ashfield Healthcare Communications and pharmaphorum attempted to answer these big questions.  

The fundamentals to building a patient-centric business  

Earlier this year, Ashfield convened a patient forum of 12 representatives from pharma companies, including large, broad portfolio companies as well as smaller/mid-sized, more specialist providers. It invited contributions from a mix of people with patient-centred roles, from Chief Patient Officer through to regional and functional patient leads.  
The participants discussed their companies’ visions for patient-centricity, the strategy and structures they were putting in place, and the key challenges they were encountering. The forum was moderated by patient advocate and former cancer patient Andrew Schorr, co-founder and director of Patient Power, along with Ashfield.  
If you would like to understand more about the findings from the patient forum and our recent webinar, click here to read our article in full, or watch our webinar on demand here.  

This article was published by Ashfield Healthcare Communications, part of UDG Healthcare plc.



1st December 2016

Share

Tags

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

Double win for Pegasus at the Communique awards 2018
We are proud to announce the recent win at the Communiqué awards for Pegasus, an Ashfield company, part of UDG Healthcare, who scooped up two awards for their Small Talk Saves Lives campaign for Samaritans. The first award won was for Excellence in Public Health and the second win was for the category Excellence in Media Relations. Read more about the campaign here. In addition, at the end of the event Pegasus was also highly recommended for Best Consultancy of the Year!
Ashfield
Ashfield Digital & Creative wins IMA Best in Class Award
We are delighted to announce that Ashfield Digital & Creative, an Ashfield company, Part of UDG Healthcare plc, have been awarded an Interactive Media Awards (IMA) Best in Class 2018 for listentotheheart.co.uk in the ‘Medical Category’.
Ashfield
Ashfield Meetings & Events strengthens creative team following increase in requests to deliver global full service live events
Ashfield Meetings & Events (part of UDG Healthcare plc) has strengthened its UK creative team, as the largest event management agency specialising in the healthcare sector sees an increase in requests to deliver full service live events for global clients.
Ashfield
Download our infographic: Addressing the biggest challenges for rare disease communities
There have been huge advances in treatment options for rare diseases. Recently these have included advanced genetic therapies, such as viral mediated gene transfer and CAR-T therapies.
Ashfield
Pegasus opens health track at Cannes Lions
This year Ashfield Healthcare Communications integrated comms agency, Pegasus, was invited to open the health track.
Ashfield
Ashfield Meetings & Events welcomes largest intake of students in seventh year of undergraduate placement scheme
Ashfield Meetings & Events, the largest full service event management agency specialising in serving the healthcare sector, has this month welcomed its largest intake of students to its highly successful university placement scheme.
Ashfield